Another study also revealed that higher mRNA expression of PRDX1/2/4/5/6 was correlated with worse prognosis, while high levels of PRDX3 were associated with favorable prognosis of patients with breast cancer [31]. Here, PRDX3 is linked to breast carcinoma.